secwatch.observer — SEC 8-K summary
======================================

Issuer:     PSYCHEMEDICS CORP (PMDI)
CIK:        0000806517
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0001171843-24-002873
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Psychemedics reports Q1 2024 revenue down 9% to $5.4M; net loss widens to $0.7M
-------------------------------------------------------------------------------

- Revenue $5.4M vs $5.9M in Q1 2023, a 9% decline.
- Net loss $0.7M ($0.12 per share) vs loss of $0.4M ($0.07) in prior year.
- CEO cites revenue decrease but remains optimistic; focusing on client acquisition and new market applications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/806517/000117184324002873/0001171843-24-002873-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/806517/000117184324002873/f8k_051424.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-002873

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer